1-4 of 4
Sabrina Kdiry
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Study Evaluating the Addition of Ublituximab and Umbralisib (U2) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL): A Minimal Residual Disease (MRD)-Driven, Time-Limited Approach

Lindsey E. Roeker, Lori A. Leslie, Jake D. Soumerai, Victoria Falco, Gail Panton, Andrew D. Zelenetz, Lorenzo Falchi, Jae H Park, Camila Pena-Velasquez, Sonia Lebowitz, Kristen Battiato, Carissa Laudati, Meghan C. Thompson, David J. Straus, Yehudit Fox, Elizabeth McCarthy, Sabrina Kdiry, Rosalba Martignetti, Hari P. Miskin, Peter Sportelli, Anthony R. Mato
Journal: Blood
Blood (2021) 138 (Supplement 1): 395.
https://doi.org/10.1182/blood-2021-146999
Published: 2021
Journal Articles

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Chaitra S. Ujjani, MD, Catherine Lai, MD MPH, Lori A. Leslie, MD, Pari Ramzi, RN, Ming Tan, Siyu Wang, Hongkun Wang, Eunice Shim, Nicole Swanson, Catherine M Broome, Ajay K. Gopal, MD, Stephen D. Smith, MD, Edus H. Warren, MD PhD, Katie Blue, Sabrina Kdiry, BSN, Brian G. Till, MD, Ryan C. Lynch, MD, Mazyar Shadman, MD MPH, Michael Johnson, Hilary Coye, PA-C, Megan Shelby, PA-C, Yolanda D. Tseng, MD, Andrei Shustov, MD, David G. Maloney, MD PhD, Bruce D. Cheson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-136219
Published: 2020
Journal Articles

A Phase I/II Study of Reduced Dose FCR (FCR-lite) in Combination with Lenalidomide Followed By Lenalidomide Maintenance (FCR 2 ) for Initial Therapy of CLL: Final Results and Long-Term Follow-up

Anthony R. Mato, MD, Andre Goy, MD, Tatyana A Feldman, MD, Joanna Rhodes, MD, Lori A. Leslie, MD, Mary Mrkulic, BS, Sabrina Kdiry, BSN, Kara Yannotti, BSN, Marisa Valentinetti, BSN, Stephen J. Schuster, MD, Jakub Svoboda, MD, Kenneth Foon, MD, Alan P Skarbnik, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3012.
https://doi.org/10.1182/blood.V130.Suppl_1.3012.3012
Published: 2017
Journal Articles

A Phase II Study of the Combination of FCR-Lite and Lenalidomide Followed By Lenalidomide Maintenance in Front-Line CLL: The FCR 2 Regimen

Anthony R. Mato, MD MSCE, Kenneth A. Foon, MD, Tatyana Feldman, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Kar Fai Chow, MD, Marisa Valentinetti, BS, Mary Morin, BS, Kelly Azzollini, BS, Gabriella Magarelli, MS, Pritish K. Bhattacharyya, MD, Joshua Zenreich, BS, Christina Howlett, PharmD, BCOP, Lauren-Nicole Pascual, BS, Kara Yanotti, BSN, Sabrina Kdiry, BSN, David Porter, MD, Andre Goy, MD
Journal: Blood
Blood (2014) 124 (21): 4678.
https://doi.org/10.1182/blood.V124.21.4678.4678
Published: 2014